Editorial: Enhancing Drug Delivery and Tumor Penetration

Enhancing Drug Delivery and Tumor PenetrationChemotherapy is vital for cancer treatment; however, most drugs used in the treatment are hydrophobic and difficult to administer.Nano-drug delivery systems (NDDS) have been widely used to transport drugs to the target site because the system improves drug bioavailability and prevents drug degradation.However, intravenously administered nanoparticles face various barriers in the body.Most nanoparticles circulating in the blood are removed by the reticuloendothelial system (RES) in the liver and spleen.Moreover, NDDS extravasation leads to drugs being distributed in the tumoral peripheral vasculature instead of penetrating the tumor.Recently, several strategies, including optimizing the physicochemical properties of nanocarriers and regulating tumor microenvironments, have been investigated to lengthen the presence of NDDS in the blood and enhance the tumor penetrating ability of NDDS.The most common method to prolong the circulation time of NDDS is to graft polyethylene glycol onto the nanocarriers.The hydrated layer formed by the stealth of polyethylene glycol can reduce the clearance by RES.To enhance tumor targeting, researchers have optimized the surface, size, shape, and zeta potential of nanocarriers in NDDS.The ideal NDDS design may be complex based on known nano-bio interactions is complex in vitro and in vivo.Many studies have elucidated the impact of nanocarrier properties in tumor delivery.Various stimuli-responsive nanocarriers have recently been developed due to the different pH values and redox states of tumor tissues.These smart NDDS do not allow drug release during blood circulation but promotes tumor targeting.Moreover, deep tumor penetration could be achieved by regulating the tumor microenvironment through interstitial fluid pressure reduction, dense stroma depletion, and nanotumor interaction regulation.This Research Topic includes two review articles and five original research articles on drug delivery and enhanced tumor penetration.Focusing on evaluating the efficacy of drug delivery, Kashkooli et al. proposed a mathematical model of drug transport to predict chemotherapeutic drug delivery, either in free form or encapsulated in nanoparticles.The study of new drug targets and drug structures is essential for drug distribution in tumors.Liang et al. summarized the recent progress in compounds containing 1,2,3-triazole to treat lung cancer and discussed their structure-activity relationship and the mechanisms of action.In the review, the authors provided a rational design of derivatives containing 1,2,3-triazole that could lead to new anticancer drugs with great efficacy against various lung cancers.Liu et al. demonstrated that downregulation of Nrf2 could inhibit invasion, metastasis, and angiogenesis of hepatoma, providing a potential therapy for hepatocellular carcinoma.Chen et al. constructed a nanodrug with improved tumor targeting by using a doxorubicin-conjugated polymer that responds to light and self-assembles to form polymeric micelles in water.Alhakamy et al. improved the anticancer efficacy of 2-methoxy

Abstract licence: CC BY

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.